Marcin Ludwik Leja
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Marcin Ludwik Leja has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Dominika Oziębło
Department of Genetics, Institute of Physiology and Pathology of Hearing, M. Mochnackiego 10, Warsaw, 02-042, Poland
10 shared publications - Henryk Skarżyński
Otorhinolaryngosurgery Clinic, World Hearing Center, Institute of Physiology and Pathology of Hearing, 02-042 Warsaw, Poland
10 shared publications - Monika Ołdak
Department of Genetics, Institute of Physiology and Pathology of Hearing, Warsaw, Poland
10 shared publications - Natalia Bałdyga
Department of Genetics, Institute of Physiology and Pathology of Hearing, M. Mochnackiego 10, Warsaw, 02-042, Poland
8 shared publications Jan Gmiński
Department of Public Health, Dietetics and Lifestyle Disorders, Faculty of Medicine, University of Information Technology and Management in Rzeszow, Sucharskiego 2, 35-225, Rzeszow, Poland
5 shared publications- Konrad Andrzej Szychowski
Department of Biotechnology and Cell Biology, Medical College, University of Information Technology and Management in Rzeszow, St. Sucharskiego 2, 35-225, Rzeszow, Poland
5 shared publications
Latest Publications
- Open Access
- 27 June 2026
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 104 (1)
Integrative genetic and functional analysis of autosomal dominant hearing loss in 108 multigenerational families
Autosomal dominant hearing loss (ADHL) is a highly heterogeneous Mendelian disorder with numerous causative genes, yet large well-characterized European cohorts remain limited. We investigated 108 families of Polish origin with confirmed dominant inheritance using a tiered strategy integrating targeted sequencing of 237 hearing loss genes, genome-wide linkage analysis, genome sequencing, segregation studies in 437 individuals, and functional validation by minigene splicing assays. This approach established a molecular diagnosis in 52% of families, with 67% of identified pathogenic variants being previously unreported. The genetic architecture proved highly heterogeneous, with recurrent contributions from MYO6, TBC1D24, WFS1, GSDME, and POU4F3 alongside numerous single-family findings. While missense variants predominated, splice-altering and truncating changes were also frequent. Importantly, genome-based analyses uncovered pathogenic mechanisms beyond canonical coding regions, including the first deep intronic EYA4 variant associated with ADHL and a large 3'UTR deletion in ATP11A affecting alternative transcripts. Functional assays confirmed aberrant splicing induced by synonymous, non-canonical splice-site, and deep intronic variants. These findings refine the gene-specific contribution to dominant hearing loss, expand the noncoding mutational landscape, and underscore the importance of integrating genomic and functional analyses for accurate variant interpretation and improved molecular diagnostics of hereditary hearing loss in clinical practice.
- 27 June 2026
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 104 (1)
Open AccessIntegrative genetic and functional analysis of autosomal dominant hearing loss in 108 multigenerational families
Autosomal dominant hearing loss (ADHL) is a highly heterogeneous Mendelian disorder with numerous causative genes, yet large well-characterized European cohorts remain limited. We investigated 108 families of Polish origin with confirmed dominant inheritance using a tiered strategy integrating targeted sequencing of 237 hearing loss genes, genome-wide linkage analysis, genome sequencing, segregation studies in 437 individuals, and functional validation by minigene splicing assays. This approach established a molecular diagnosis in 52% of families, with 67% of identified pathogenic variants being previously unreported. The genetic architecture proved highly heterogeneous, with recurrent contributions from MYO6, TBC1D24, WFS1, GSDME, and POU4F3 alongside numerous single-family findings. While missense variants predominated, splice-altering and truncating changes were also frequent. Importantly, genome-based analyses uncovered pathogenic mechanisms beyond canonical coding regions, including the first deep intronic EYA4 variant associated with ADHL and a large 3'UTR deletion in ATP11A affecting alternative transcripts. Functional assays confirmed aberrant splicing induced by synonymous, non-canonical splice-site, and deep intronic variants. These findings refine the gene-specific contribution to dominant hearing loss, expand the noncoding mutational landscape, and underscore the importance of integrating genomic and functional analyses for accurate variant interpretation and improved molecular diagnostics of hereditary hearing loss in clinical practice.
- 11 February 2025
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 34 (9) , 765-776
Characterization of a novel GRHL2 mutation reveals molecular mechanisms underlying autosomal dominant hearing loss (DFNA28): insights from structural and functional studies
The GRHL2 gene, encoding the Grainyhead-like 2 transcription factor, is essential for various biological processes. While GRHL2 has a complex role in cancer biology, its genetic variants have been also implicated in different forms of hearing loss (HL), including autosomal dominant non-syndromic hearing loss (DFNA28). Here, we report a novel c.1061C>T, p.(Ala354Val) mutation within the DNA binding domain (DBD) of GRHL2 that was identified in a three-generation HL family using a targeted multi-gene panel covering 237 HL-related genes. Unlike the previously reported DFNA28-causing variants that result in protein truncation, the impact of the p.(Ala354Val) missense change cannot be attributed to GRHL2 transcript level or composition, but to an alteration in protein function. Molecular dynamics simulations revealed destabilization of the p.(Ala354Val) mutant GRHL2 dimer interface and an altered DNA binding dynamics, leading to chaotic interaction patterns despite increased binding affinity to DNA. Functional assays demonstrated that the p.(Ala354Val) mutation and other DFNA28-related mutations in the DBD lead to loss of GRHL2 transcriptional transactivation activity, while the p.(Arg537Profs*11) mutation in the dimerization domain results in a gain-of-function effect. The findings indicate that both GRHL2 haploinsufficiency and gain-of-function contribute to HL and underscore the complex regulatory role of GRHL2 in maintaining proper function of the auditory system. Our study emphasizes the need to consider structural and functional aspects of gene variants to better understand their pathogenic potential. As GRHL2 is involved in a multitude of cellular processes, the data gathered here can be also applicable to other conditions.
- 11 February 2025
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 34 (9) , 765-776
Characterization of a novel GRHL2 mutation reveals molecular mechanisms underlying autosomal dominant hearing loss (DFNA28): insights from structural and functional studies
The GRHL2 gene, encoding the Grainyhead-like 2 transcription factor, is essential for various biological processes. While GRHL2 has a complex role in cancer biology, its genetic variants have been also implicated in different forms of hearing loss (HL), including autosomal dominant non-syndromic hearing loss (DFNA28). Here, we report a novel c.1061C>T, p.(Ala354Val) mutation within the DNA binding domain (DBD) of GRHL2 that was identified in a three-generation HL family using a targeted multi-gene panel covering 237 HL-related genes. Unlike the previously reported DFNA28-causing variants that result in protein truncation, the impact of the p.(Ala354Val) missense change cannot be attributed to GRHL2 transcript level or composition, but to an alteration in protein function. Molecular dynamics simulations revealed destabilization of the p.(Ala354Val) mutant GRHL2 dimer interface and an altered DNA binding dynamics, leading to chaotic interaction patterns despite increased binding affinity to DNA. Functional assays demonstrated that the p.(Ala354Val) mutation and other DFNA28-related mutations in the DBD lead to loss of GRHL2 transcriptional transactivation activity, while the p.(Arg537Profs*11) mutation in the dimerization domain results in a gain-of-function effect. The findings indicate that both GRHL2 haploinsufficiency and gain-of-function contribute to HL and underscore the complex regulatory role of GRHL2 in maintaining proper function of the auditory system. Our study emphasizes the need to consider structural and functional aspects of gene variants to better understand their pathogenic potential. As GRHL2 is involved in a multitude of cellular processes, the data gathered here can be also applicable to other conditions.
- Open Access
- 1 January 2025
- Published by Institute of Sensory Organs in Nowa Audiofonologia
- Vol. 14 (4) , 9-18
Advances in genetic diagnostics and the mystery of missing heredity: Where does the genetic cause of molecularly unexplained hereditary hearing loss hide?
Niedosłuch (HL) może mieć zarówno podłoże genetyczne, jak i środowiskowe. Genetycznie uwarunkowany HL może występować jako cecha izolowana lub stanowić jeden z objawów zespołu genetycznie uwarunkowanego. Badania genetyczne odgrywają ważną rolę w identyfikowaniu przyczyn izolowanego i syndromicznego HL. Pomimo że z HL izolowanym powiązano ponad 150 genów oraz znanych jest ponad 400 zespołów, których charakterystycznym objawem jest HL, w wielu przypadkach nie udaje się ustalić molekularnej przyczyny HL. Zjawisko to określane jest jako utracona dziedziczność. Istnieje kilka różnych wyjaśnień nierozwiązanych genetycznie przypadków HL, które omówione zostały w poniższym artykule. W ostatnich latach znacząco wzrosły możliwości diagnostyki genetycznej pacjentów, możliwa jest jednoczesna analiza wielu genów dzięki zastosowaniu testów wysokoprzepustowych, takich jak sekwencjonowanie następnej generacji (NGS). Szybki postęp technologiczny w diagnostyce genetycznej chorób rzadkich niesie za sobą ogromne wyzwania w analizie i interpretacji otrzymywanych wyników, dlatego istotną rolę odgrywają także badania funkcjonalne z użyciem modeli komórkowych i zwierzęcych, w tym myszy i dania pręgowanego (Danio rerio). Istnieje nieustanna potrzeba badań w kierunku pełnego zrozumienia mechanizmów molekularnych powstawania chorób rzadkich, w tym dziedzicznego HL, z zastosowaniem najnowszych rozwiązań bioinformatycznych wspierających precyzyjną diagnozę.
- 1 January 2025
- Published by Institute of Sensory Organs in Nowa Audiofonologia
- Vol. 14 (4) , 9-18
Open AccessAdvances in genetic diagnostics and the mystery of missing heredity: Where does the genetic cause of molecularly unexplained hereditary hearing loss hide?
Niedosłuch (HL) może mieć zarówno podłoże genetyczne, jak i środowiskowe. Genetycznie uwarunkowany HL może występować jako cecha izolowana lub stanowić jeden z objawów zespołu genetycznie uwarunkowanego. Badania genetyczne odgrywają ważną rolę w identyfikowaniu przyczyn izolowanego i syndromicznego HL. Pomimo że z HL izolowanym powiązano ponad 150 genów oraz znanych jest ponad 400 zespołów, których charakterystycznym objawem jest HL, w wielu przypadkach nie udaje się ustalić molekularnej przyczyny HL. Zjawisko to określane jest jako utracona dziedziczność. Istnieje kilka różnych wyjaśnień nierozwiązanych genetycznie przypadków HL, które omówione zostały w poniższym artykule. W ostatnich latach znacząco wzrosły możliwości diagnostyki genetycznej pacjentów, możliwa jest jednoczesna analiza wielu genów dzięki zastosowaniu testów wysokoprzepustowych, takich jak sekwencjonowanie następnej generacji (NGS). Szybki postęp technologiczny w diagnostyce genetycznej chorób rzadkich niesie za sobą ogromne wyzwania w analizie i interpretacji otrzymywanych wyników, dlatego istotną rolę odgrywają także badania funkcjonalne z użyciem modeli komórkowych i zwierzęcych, w tym myszy i dania pręgowanego (Danio rerio). Istnieje nieustanna potrzeba badań w kierunku pełnego zrozumienia mechanizmów molekularnych powstawania chorób rzadkich, w tym dziedzicznego HL, z zastosowaniem najnowszych rozwiązań bioinformatycznych wspierających precyzyjną diagnozę.
- Open Access
- 31 March 2023
- Published by Institute of Sensory Organs in Nowa Audiofonologia
- Vol. 12 (1) , 16-43
Autosomal dominant hearing loss – literature review
Niedosłuch dziedziczony w sposób autosomalny dominujący (ADHL) jest drugim co do częstości typem HL dziedzicznego. Zwykle rozwija się postlingwalnie i ma charakter postępujący. Rodowód rodzin z ADHL charakteryzuje się występowaniem choroby w kolejnych pokoleniach, jednak u części rodzin HL może występować sporadycznie, gdy wariant patogenny powstał de novo. Wraz z postępem wiedzy i rozwojem technologicznym zwiększa się wykrywalność wariantów patogennych w genach istotnych dla funkcjonowania narządu słuchu i równowagi, identyfikowane są również nowe geny. W pracy przedstawione zostały wyniki analizy dostępnej literatury dotyczącej genetycznego podłoża ADHL i jego charakterystyki klinicznej. Istotną część pracy stanowi tabela zawierająca każdy z dotychczas poznanych genów ADHL wraz z informacjami dotyczącymi: wieku wystąpienia HL, stopnia ubytku słuchu, charakteru i profilu audiologicznego HL, jak również współwystępowania szumów usznych i zaburzeń funkcji przedsionka.
- 31 March 2023
- Published by Institute of Sensory Organs in Nowa Audiofonologia
- Vol. 12 (1) , 16-43
Open AccessAutosomal dominant hearing loss – literature review
Niedosłuch dziedziczony w sposób autosomalny dominujący (ADHL) jest drugim co do częstości typem HL dziedzicznego. Zwykle rozwija się postlingwalnie i ma charakter postępujący. Rodowód rodzin z ADHL charakteryzuje się występowaniem choroby w kolejnych pokoleniach, jednak u części rodzin HL może występować sporadycznie, gdy wariant patogenny powstał de novo. Wraz z postępem wiedzy i rozwojem technologicznym zwiększa się wykrywalność wariantów patogennych w genach istotnych dla funkcjonowania narządu słuchu i równowagi, identyfikowane są również nowe geny. W pracy przedstawione zostały wyniki analizy dostępnej literatury dotyczącej genetycznego podłoża ADHL i jego charakterystyki klinicznej. Istotną część pracy stanowi tabela zawierająca każdy z dotychczas poznanych genów ADHL wraz z informacjami dotyczącymi: wieku wystąpienia HL, stopnia ubytku słuchu, charakteru i profilu audiologicznego HL, jak również współwystępowania szumów usznych i zaburzeń funkcji przedsionka.
- Open Access
The Genetic Background of Hearing Loss in Patients with EVA and Cochlear Malformation
The most frequently observed congenital inner ear malformation is enlarged vestibular aqueduct (EVA). It is often accompanied with incomplete partition type 2 (IP2) of the cochlea and a dilated vestibule, which together constitute Mondini malformation. Pathogenic SLC26A4 variants are considered the major cause of inner ear malformation but the genetics still needs clarification. The aim of this study was to identify the cause of EVA in patients with hearing loss (HL). Genomic DNA was isolated from HL patients with radiologically confirmed bilateral EVA (n = 23) and analyzed by next generation sequencing using a custom HL gene panel encompassing 237 HL-related genes or a clinical exome. The presence and segregation of selected variants and the CEVA haplotype (in the 5′ region of SLC26A4) was verified by Sanger sequencing. Minigene assay was used to evaluate the impact of novel synonymous variant on splicing. Genetic testing identified the cause of EVA in 17/23 individuals (74%). Two pathogenic variants in the SLC26A4 gene were identified as the cause of EVA in 8 of them (35%), and a CEVA haplotype was regarded as the cause of EVA in 6 of 7 patients (86%) who carried only one SLC26A4 genetic variant. In two individuals with a phenotype matching branchio-oto-renal (BOR) spectrum disorder, cochlear hypoplasia resulted from EYA1 pathogenic variants. In one patient, a novel variant in CHD7 was detected. Our study shows that SLC26A4, together with the CEVA haplotype, accounts for more than half of EVA cases. Syndromic forms of HL should also be considered in patients with EVA. We conclude that to better understand inner ear development and the pathogenesis of its malformations, there is a need to look for pathogenic variants in noncoding regions of known HL genes or to link them with novel candidate HL genes.
Open AccessThe Genetic Background of Hearing Loss in Patients with EVA and Cochlear Malformation
The most frequently observed congenital inner ear malformation is enlarged vestibular aqueduct (EVA). It is often accompanied with incomplete partition type 2 (IP2) of the cochlea and a dilated vestibule, which together constitute Mondini malformation. Pathogenic SLC26A4 variants are considered the major cause of inner ear malformation but the genetics still needs clarification. The aim of this study was to identify the cause of EVA in patients with hearing loss (HL). Genomic DNA was isolated from HL patients with radiologically confirmed bilateral EVA (n = 23) and analyzed by next generation sequencing using a custom HL gene panel encompassing 237 HL-related genes or a clinical exome. The presence and segregation of selected variants and the CEVA haplotype (in the 5′ region of SLC26A4) was verified by Sanger sequencing. Minigene assay was used to evaluate the impact of novel synonymous variant on splicing. Genetic testing identified the cause of EVA in 17/23 individuals (74%). Two pathogenic variants in the SLC26A4 gene were identified as the cause of EVA in 8 of them (35%), and a CEVA haplotype was regarded as the cause of EVA in 6 of 7 patients (86%) who carried only one SLC26A4 genetic variant. In two individuals with a phenotype matching branchio-oto-renal (BOR) spectrum disorder, cochlear hypoplasia resulted from EYA1 pathogenic variants. In one patient, a novel variant in CHD7 was detected. Our study shows that SLC26A4, together with the CEVA haplotype, accounts for more than half of EVA cases. Syndromic forms of HL should also be considered in patients with EVA. We conclude that to better understand inner ear development and the pathogenesis of its malformations, there is a need to look for pathogenic variants in noncoding regions of known HL genes or to link them with novel candidate HL genes.
- Open Access
- 27 May 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (11) , 6029
Searching for the Molecular Basis of Partial Deafness
Hearing is an important human sense for communicating and connecting with others. Partial deafness (PD) is a common hearing problem, in which there is a down-sloping audiogram. In this study, we apply a practical system for classifying PD patients, used for treatment purposes, to distinguish two groups of patients: one with almost normal hearing thresholds at low frequencies (PDT-EC, n = 20), and a second group with poorer thresholds at those same low frequencies (PDT-EAS, n = 20). After performing comprehensive genetic testing with a panel of 237 genes, we found that genetic factors can explain a significant proportion of both PDT-EC and PDT-EAS hearing losses, accounting, respectively, for approx. one-fifth and one-half of all the cases in our cohort. Most of the causative variants were located in dominant and recessive genes previously linked to PD, but more than half of the variants were novel. Among the contributors to PDT-EC we identified OSBPL2 and SYNE4, two relatively new hereditary hearing loss genes with a low publication profile. Our study revealed that, for all PD patients, a postlingual hearing loss more severe in the low-frequency range is associated with a higher detection rate of causative variants. Isolating a genetic cause of PD is important in terms of prognosis, therapeutic effectiveness, and risk of recurrence.
- 27 May 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (11) , 6029
Open AccessSearching for the Molecular Basis of Partial Deafness
Hearing is an important human sense for communicating and connecting with others. Partial deafness (PD) is a common hearing problem, in which there is a down-sloping audiogram. In this study, we apply a practical system for classifying PD patients, used for treatment purposes, to distinguish two groups of patients: one with almost normal hearing thresholds at low frequencies (PDT-EC, n = 20), and a second group with poorer thresholds at those same low frequencies (PDT-EAS, n = 20). After performing comprehensive genetic testing with a panel of 237 genes, we found that genetic factors can explain a significant proportion of both PDT-EC and PDT-EAS hearing losses, accounting, respectively, for approx. one-fifth and one-half of all the cases in our cohort. Most of the causative variants were located in dominant and recessive genes previously linked to PD, but more than half of the variants were novel. Among the contributors to PDT-EC we identified OSBPL2 and SYNE4, two relatively new hereditary hearing loss genes with a low publication profile. Our study revealed that, for all PD patients, a postlingual hearing loss more severe in the low-frequency range is associated with a higher detection rate of causative variants. Isolating a genetic cause of PD is important in terms of prognosis, therapeutic effectiveness, and risk of recurrence.
- 7 March 2022
- Published by Springer Nature in Human Genetics
- Vol. 141 (3-4) , 445-453
Update on CD164 and LMX1A genes to strengthen their causative role in autosomal dominant hearing loss
Novel hearing loss (HL) genes are constantly being discovered, and evidence from independent studies is essential to strengthen their position as causes of hereditary HL. To address this issue, we searched our genetic data of families with autosomal dominant HL (ADHL) who had been tested with high-throughput DNA sequencing methods. For CD164, only one pathogenic variant in one family has so far been reported. For LMX1A, just two previous studies have revealed its involvement in ADHL. In this study we found two families with the same pathogenic variant in CD164 and one family with a novel variant in LMX1A (c.686C>A; p.(Ala229Asp)) that impairs its transcriptional activity. Our data show recurrence of the same CD164 variant in two HL families of different geographic origin, which strongly suggests it is a mutational hotspot. We also provide further evidence for haploinsufficiency as the pathogenic mechanism underlying LMX1A-related ADHL.
- 7 March 2022
- Published by Springer Nature in Human Genetics
- Vol. 141 (3-4) , 445-453
Update on CD164 and LMX1A genes to strengthen their causative role in autosomal dominant hearing loss
Novel hearing loss (HL) genes are constantly being discovered, and evidence from independent studies is essential to strengthen their position as causes of hereditary HL. To address this issue, we searched our genetic data of families with autosomal dominant HL (ADHL) who had been tested with high-throughput DNA sequencing methods. For CD164, only one pathogenic variant in one family has so far been reported. For LMX1A, just two previous studies have revealed its involvement in ADHL. In this study we found two families with the same pathogenic variant in CD164 and one family with a novel variant in LMX1A (c.686C>A; p.(Ala229Asp)) that impairs its transcriptional activity. Our data show recurrence of the same CD164 variant in two HL families of different geographic origin, which strongly suggests it is a mutational hotspot. We also provide further evidence for haploinsufficiency as the pathogenic mechanism underlying LMX1A-related ADHL.
- Open Access
- 1 December 2021
- Published by Institute of Sensory Organs in Journal of Hearing Science
- Vol. 11 (4) , 72-76
POSTLINGUAL SENSORINEURAL HEARING LOSS DUE TO KNOWN TBC1D24 GENE ALTERATION
Background: Genetically determined hearing loss (HL) can be inherited in two major ways - autosomal recessive or dominant. Autosomal dominant hearing loss (ADHL) is usually postlingual and progressive. To date, 50 different genes have been demonstrated to be causally involved in its...
- 1 December 2021
- Published by Institute of Sensory Organs in Journal of Hearing Science
- Vol. 11 (4) , 72-76
Open AccessPOSTLINGUAL SENSORINEURAL HEARING LOSS DUE TO KNOWN TBC1D24 GENE ALTERATION
Background: Genetically determined hearing loss (HL) can be inherited in two major ways - autosomal recessive or dominant. Autosomal dominant hearing loss (ADHL) is usually postlingual and progressive. To date, 50 different genes have been demonstrated to be causally involved in its...
- Open Access
- 13 May 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-14
TBC1D24 emerges as an important contributor to progressive postlingual dominant hearing loss
Several TBC1D24 variants are causally involved in the development of profound, prelingual hearing loss (HL) and different epilepsy syndromes inherited in an autosomal recessive manner. Only two TBC1D24 pathogenic variants have been linked with postlingual progressive autosomal dominant HL (ADHL). To determine the role of TBC1D24 in the development of ADHL and to characterize the TBC1D24-related ADHL, clinical exome sequencing or targeted multigene (n = 237) panel were performed for probands (n = 102) from multigenerational ADHL families. In four families, TBC1D24-related HL was found based on the identification of three novel, likely pathogenic (c.553G>A, p.Asp185Asn; c.1460A>T, p. His487Leu or c.1461C>G, p.His487Gln) and one known (c.533C>T, p.Ser178Leu) TBC1D24 variant. Functional consequences of these variants were characterized by analyzing the proposed homology models of the human TBC1D24 protein. Variants not only in the TBC (p.Ser178Leu, p.Asp185Asn) but also in the TLDc domain (p.His487Gln, p.His487Leu) are involved in ADHL development, the latter two mutations probably affecting interactions between the domains. Clinically, progressive HL involving mainly mid and high frequencies was observed in the patients (n = 29). The progression of HL was calculated by constructing age-related typical audiograms. TBC1D24-related ADHL originates from the cochlear component of the auditory system, becomes apparent usually in the second decade of life and accounts for approximately 4% of ADHL cases. Given the high genetic heterogeneity of ADHL, TBC1D24 emerges as an important contributor to this type of HL.
- 13 May 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-14
Open AccessTBC1D24 emerges as an important contributor to progressive postlingual dominant hearing loss
Several TBC1D24 variants are causally involved in the development of profound, prelingual hearing loss (HL) and different epilepsy syndromes inherited in an autosomal recessive manner. Only two TBC1D24 pathogenic variants have been linked with postlingual progressive autosomal dominant HL (ADHL). To determine the role of TBC1D24 in the development of ADHL and to characterize the TBC1D24-related ADHL, clinical exome sequencing or targeted multigene (n = 237) panel were performed for probands (n = 102) from multigenerational ADHL families. In four families, TBC1D24-related HL was found based on the identification of three novel, likely pathogenic (c.553G>A, p.Asp185Asn; c.1460A>T, p. His487Leu or c.1461C>G, p.His487Gln) and one known (c.533C>T, p.Ser178Leu) TBC1D24 variant. Functional consequences of these variants were characterized by analyzing the proposed homology models of the human TBC1D24 protein. Variants not only in the TBC (p.Ser178Leu, p.Asp185Asn) but also in the TLDc domain (p.His487Gln, p.His487Leu) are involved in ADHL development, the latter two mutations probably affecting interactions between the domains. Clinically, progressive HL involving mainly mid and high frequencies was observed in the patients (n = 29). The progression of HL was calculated by constructing age-related typical audiograms. TBC1D24-related ADHL originates from the cochlear component of the auditory system, becomes apparent usually in the second decade of life and accounts for approximately 4% of ADHL cases. Given the high genetic heterogeneity of ADHL, TBC1D24 emerges as an important contributor to this type of HL.
- Open Access
- 26 October 2019
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 17 (1) , 1-7
First confirmatory study on PTPRQ as an autosomal dominant non-syndromic hearing loss gene
Background: Biallelic PTPRQ pathogenic variants have been previously reported as causative for autosomal recessive non-syndromic hearing loss. In 2018 the first heterozygous PTPRQ variant has been implicated in the development of autosomal dominant non-syndromic hearing loss (ADNSHL) in a German family. The study presented the only, so far known, PTPRQ pathogenic variant (c.6881G>A) in ADNSHL. It is located in the last PTPRQ coding exon and introduces a premature stop codon (p.Trp2294*). Methods: A five-generation Polish family with ADNSHL was recruited for the study (n = 14). Thorough audiological, neurotological and imaging studies were carried out to precisely define the phenotype. Genomic DNA was isolated from peripheral blood samples or buccal swabs of available family members. Clinical exome sequencing was conducted for the proband. Family segregation analysis of the identified variants was performed using Sanger sequencing. Single nucleotide polymorphism array on DNA samples from the Polish and the original German family was used for genome-wide linkage analysis. Results: Combining clinical exome sequencing and family segregation analysis, we have identified the same (NM_001145026.2:c.6881G>A, NP_001138498.1:p.Trp2294*) PTPRQ alteration in the Polish ADNSHL family. Using genome-wide linkage analysis, we found that the studied family and the original German family derive from a common ancestor. Deep phenotyping of the affected individuals showed that in contrast to the recessive form, the PTPRQ-related ADNSHL is not associated with vestibular dysfunction. In both families ADNSHL was progressive, affected mainly high frequencies and had a variable age of onset. Conclusion: Our data provide the first confirmation of PTPRQ involvement in ADNSHL. The finding strongly reinforces the inclusion of PTPRQ to the small set of genes leading to both autosomal recessive and dominant hearing loss.
- 26 October 2019
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 17 (1) , 1-7
Open AccessFirst confirmatory study on PTPRQ as an autosomal dominant non-syndromic hearing loss gene
Background: Biallelic PTPRQ pathogenic variants have been previously reported as causative for autosomal recessive non-syndromic hearing loss. In 2018 the first heterozygous PTPRQ variant has been implicated in the development of autosomal dominant non-syndromic hearing loss (ADNSHL) in a German family. The study presented the only, so far known, PTPRQ pathogenic variant (c.6881G>A) in ADNSHL. It is located in the last PTPRQ coding exon and introduces a premature stop codon (p.Trp2294*). Methods: A five-generation Polish family with ADNSHL was recruited for the study (n = 14). Thorough audiological, neurotological and imaging studies were carried out to precisely define the phenotype. Genomic DNA was isolated from peripheral blood samples or buccal swabs of available family members. Clinical exome sequencing was conducted for the proband. Family segregation analysis of the identified variants was performed using Sanger sequencing. Single nucleotide polymorphism array on DNA samples from the Polish and the original German family was used for genome-wide linkage analysis. Results: Combining clinical exome sequencing and family segregation analysis, we have identified the same (NM_001145026.2:c.6881G>A, NP_001138498.1:p.Trp2294*) PTPRQ alteration in the Polish ADNSHL family. Using genome-wide linkage analysis, we found that the studied family and the original German family derive from a common ancestor. Deep phenotyping of the affected individuals showed that in contrast to the recessive form, the PTPRQ-related ADNSHL is not associated with vestibular dysfunction. In both families ADNSHL was progressive, affected mainly high frequencies and had a variable age of onset. Conclusion: Our data provide the first confirmation of PTPRQ involvement in ADNSHL. The finding strongly reinforces the inclusion of PTPRQ to the small set of genes leading to both autosomal recessive and dominant hearing loss.